144 results on '"Hansen, B."'
Search Results
2. Comparison of treatments for solitary, small hepatocellular carcinoma: a network meta-analysis
3. The Female Risk Factors for Post-Infarction Depression and Anxiety (FRIDA) Study: Quality of Life and MACE Post-Acute Coronary Syndrome
4. Drinking water magnesium and cardiovascular mortality: A cohort study in Denmark, 2005–2016
5. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
6. NASH vs. Non-NASH HCC within and Beyond Milan Criteria in Liver Transplantation for Hepatocellular Carcinoma
7. Assessment of chloride natural background levels by applying statistical approaches. Analyses of European coastal aquifers in different environments
8. Impact of Neoadjuvant Chemotherapy on Post-Operative Outcomes of Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma: ACS-NSQIP Propensity-Matched Analysis
9. Preoperative Neutrophil-To-Lymphocyte Ratio Is Prognostic for Early Recurrence after Curative Intrahepatic Cholangiocarcinoma Resection
10. Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis
11. Assessing the viability of the ACT natural gas distribution network for reuse as a hydrogen distribution network
12. The impact of geographical region on outcomes of patients with primary biliary cholangitis from western Europe
13. Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on the alkaline phosphatase
14. Preoperative neutrophil-to-lymphocyte ratio is prognostic for recurrence within the first 12 months after curative intrahepatic cholangiocarcinoma resection
15. Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase
16. Role of Nuclear Medicine in Imaging
17. Investigation of the tribological behavior of car body parts in series production
18. Histologic stage is a stronger predictor of transplant free survival than APRI and FIB-4 in patients with primary biliary cholangitis
19. HBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B
20. Comparison of event-free survival between DAA and IFN-based antiviral therapy for HCV, adjusted for disease severity
21. Serum immune signatures predict HCC development in DAA-treated HCV patients
22. Low serum HBsAg and HBV DNA predict response of peg-interferon addition to entecavir in HBeAg positive chronic hepatitis B
23. The natural course of FIC1 deficiency and BSEP deficiency: Initial results from the NAPPED-consortium (Natural course and Prognosis of PFIC and Effect of biliary Diversion)
24. Ursodeoxycholic acid treatment is associated with prolonged transplant-free survival in primary biliary cholangitis – even in patients without biochemical improvements
25. Sustained virological suppression and improved renal function with reduced dose tenofovir disoproxil fumarate in renally compromised patients with chronic hepatitis B
26. Time trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades
27. The number needed to treat to prevent one clinical event at 2 years after antiviral treatment for HCV with DAAs compared to IFN-based therapy
28. Younger age is associated with lower transplant-free survival relative to a general population in patients with Primary Biliary Cholangitis
29. A dose-response relationship in the association between ursodeoxycholic acid treatment and prolonged transplant-free survival in primary biliary cholangitis
30. Stratification of hepatocellular carcinoma risk using the GLOBE score in patients with primary biliary cholangitis– the Global PBC Study Group
31. Spontaneous clearance of HCV RNA after documented relapse following DAA-therapy: A case-control study
32. Impact of genotype 3 on clinical outcome in patients with hepatitis C: both diabetes meliitus and liver disease progression
33. Risk reduction with obeticholic acid in patients not achieving the POISE primary endpoint
34. Durable response in the markers of cholestasis through 18 months of open-label extension with obeticholic acid in primary biliary cholangitis
35. Cholestasis is not Associated with Liver Stiffness in a Population-Based Cohort
36. Previous Interferon Treatment Failure is Associated with Avery Low Chance of Response to Peginterferon Retreatment in HBeAg-Positive Chronic Hepatitis B: Pooled Analysis of Two Randomized Trials
37. Impact of Infections on Waiting List Survival in Patients with End Stage Liver Disease
38. Real-World Medical Costs of Antiviral Therapy Among Patients With Chronic Hcv Infection and Advanced Hepatic Fibrosis
39. P0669 : Consolidation therapy with entecavir can prevent post-treatment HBsAg rebound in HBeAg-positive chronic hepatitis B patients treated with peginterferon alpha
40. P1321 : A phase 3B, double blind, placebo controlled study evaluating the effect of obeticholic acid on clinical outcomes in subjects with primary biliary cirrhosis at elevated risk of progression to liver transplant or death
41. P0690 : IFN-free therapy for chronic HCV: Transcriptomics and NK cell analyses
42. Associations between knee pain and synovitis on conventional and dynamic contrast-enhanced magnetic resonance imaging in obese persons with knee osteoarthritis: A cross-sectional study
43. Two-year carcinogenicity study of acrylamide in Wistar Han rats with in utero exposure
44. O132 EFFECTIVE STRATIFICATION OF HEPATOCELLULAR CARCINOMA RISK IN PRIMARY BILIARY CIRRHOSIS: RESULTS OF A MULTI-CENTRE INTERNATIONAL STUDY
45. O168 THE FIRST PRIMARY BILIARY CIRRHOSIS (PBC) PHASE 3 TRIAL IN TWO DECADES – AN INTERNATIONAL STUDY OF THE FXR AGONIST OBETICHOLIC ACID IN PBC PATIENTS
46. Self- and parent reported sleep problems in children and youths with epilepsy. Preliminary findings from a study in a tertiary epilepsy center
47. Reliability and discriminatory testing of a client-based metrology instrument, feline musculoskeletal pain index (FMPI) for the evaluation of degenerative joint disease-associated pain in cats
48. 1347 ASSOCIATION OF PSORIASIS WITH NONALCOHOLIC FATTY LIVER DISEASE: RESULTS FROM A POPULATION-BASED STUDY
49. 737 POLYMORPHISMS NEAR THE IL28B GENE ARE NOT ASSOCIATED WITH RESPONSE TO PEGINTERFERON IN HBeAg-NEGATIVE CHRONIC HEPATITIS B PATIENTS
50. Which goal for fluid therapy during colorectal surgery is followed by the best outcome: near-maximal stroke volume or zero fluid balance?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.